CREKA peptide
CREKA peptide is a short peptide with self-assembly properties, and its sequence is Cys-Arg-Glu-Lys-Ala (CREKA). This short peptide can achieve targeted localization of the lesion site by specifically recognizing and binding to the overexpressed fibrin in the lesion tissue. Studies have shown that CREKA peptide can effectively target disease areas such as cancer, myocardial ischemia-reperfusion injury and atherosclerosis. Due to its excellent targeting and self-assembly capabilities, CREKA peptide has broad application prospects in the field of nanomedicine technology. It can be used to construct targeted drug delivery systems, diagnostic imaging probes, and therapeutic nanomaterials, and is expected to improve the accuracy and effectiveness of disease diagnosis and treatment.
Storage | Store at -20°C for 3 years. |
M.Wt | 605.71 |
Cas No. | 847058-45-1 |
Formula | C23H43N9O8S |
Solubility | Soluble in DMSO |
Chemical Name | (6S,9S,12S,15S)-1-amino-6-((R)-2-amino-3-mercaptopropanamido)-12-(4-aminobutyl)-9-(2-carboxyethyl)-1-imino-15-methyl-7,10,13-trioxo-2,8,11,14-tetraazahexadecan-16-oic acid |
SDF | Download SDF |
Canonical SMILES | SC[C@H](N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCC(O)=O)C(N[C@@H](CCCCN)C(N[C@@H](C)C(O)=O)=O)=O)=O)=O |
Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
General tips | We do not recommend long-term storage for the solution, please use it up soon. |